Everything You Need to Know about the

Neuropsychiatric Research Center Of Southwest Florida


  • Frederick W. Schaerf, M.D., Ph.D. and Wendy R. Bond, M.D. have conducted over 100 clinical trials dedicated to dementia. You will receive the latest diagnostics and treatments available in a safe, well controlled environment.
  • We do not conduct studies that require subjects to stop taking their current medications.
  • The medications that we are investigating have been tested in earlier trials for safety and tolerability. We have never placed our patients at risk and we never will.
  • All of your site visits, tests, and medications are free of charge. This includes travel fees as we can arrange for travel accommodations. There is no·insurance requirement and we will not ask you for proof of insurance.
  • You will need a study partner to attend your visits to the office and help track the progress throughout the trial duration. You both have access to educational materials and focus groups in order to better educate you and your partner about dementia.
  • Our office is a doctor's office. There are no guinea pigs nor will you ever be treated like one. You and your study partner will be treated with dignity and care. You are welcome and encouraged to schedule a free visit to meet with our friendly, professional staff (239-939-7777).
  • You may receive a referral from your physician to contact our office, or you may simply call our office to learn more about your eligibility (239-939-7777). Your primary care physician will be kept informed.
  • You must satisfy several criteria which are determined via a phone screening with one of our staff and then a pre­ screening process with one of our clinicians at our office. This pre-screening process may include, but not limitedly, an MRI and/or PET scan, standard tests of cognitive function and analysis of blood and urine chemistry at no cost to you.
  • Some studies require a Lumbar Puncture. Do not be alarmed. A Lumbar Puncture is a very tiny prick and is conducted under fluoroscopy.
  • Disqualification from a clinical trial can occur and can be related to your other medical conditions or the·medications you currently take. Please do not lose hope or be discouraged! Even if you do not qualify for a study, we will still recommend the highest quality medical and educational resources available. Additionally, with your permission, we will contact you for future studies that you might qualify for.
  • Informed consent must be obtained from the participant and study partner in order for the screening process to begin. You will know exactly what is expected of you before agreeing to participate. You may withdraw from the study at any point and/or any reason with no penalties. We will fully support your decision.
  • Participating in a trial means you will learn more about the disease affecting you and potentially receive a medication not available by prescription. You will be playing an active role in the development of a potentially disease altering medication.
  • You may receive a placebo as part of the study. We do not know if you are on the placebo or actual drug. If you are on the placebo, and the drug proves effective, there may be an open label extension where you will receive the drug up until it is available by prescription.
  • The treatment of memory loss is changing. Early diagnosis is clinically important and earlier interventions are being actively studied.
  • We thoroughly understand the disease that is impacting your life. While you may remain under the care of your current physician(s), we will treat you with the highest level of empathy, dignity, and professionalism while under our supervision. Education is the cornerstone of the clinical trials process and the families that benefit most from this process are those needing answers and support. You will receive both at the Neuropsychiatric Research Center of Southwest Florida.
  • The Neuropsychiatric Research Center of Southwest Florida is dedicated in finding effective treatments for those with Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Early detection is as crucial a component for treating this disease as the treatments themselves.  We are committed to bringing the best advancements in clinical research trials being conducted all over the world, and making them available to patients in Southwest Florida.




For more information please contact the

Neuropsychiatric Research Center of Southwest Florida



Neuropsychiatric Research Center of Southwest Florida, llc

An ERG Portfolio Company

14271 Metropolis Avenue, Suite A • Fort Myers, FL  33912